OKYO Pharma logo

EMMW - OKYO Pharma News Story

€0.017 0.0  0.0%

Last Trade - 12/09/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 1040

BRIEF-Okyo Pharma Ltd announces admission to LSE's Main Market trading

Tue 17th July, 2018 7:12am
July 17 (Reuters) - OKYO Pharma Corporation  EMMW.SG :
    * OKYO PHARMA LIMITED ANNOUNCES THAT ITS ENTIRE ISSUED SHARE
CAPITAL HAS BEEN ADMITTED TO LISTING ON STANDARD SEGMENT OF
OFFICIAL LIST OF FINANCIAL CONDUCT AUTHORITY AND TO TRADING ON
MAIN MARKET FOR LISTED SECURITIES OF LONDON STOCK EXCHANGE PLC
    * THE TOTAL NUMBER OF ORDINARY SHARES IN THE COMPANY IN
ISSUE
IMMEDIATELY FOLLOWING ADMISSION IS 523,595,417 EACH WITH EQUAL
VOTING RIGHTS. 
    * THIS TOTAL VOTING RIGHTS FIGURE CAN BE USED BY
SHAREHOLDERS AS
THE DENOMINATOR FOR THE CALCULATIONS BY WHICH THEY WILL
DETERMINE WHETHER THEY ARE REQUIRED TO NOTIFY THEIR INTEREST IN
THE COMPANY UNDER THE DISCLOSURE GUIDANCE AND TRANSPARENCY RULES
OF THE FCA

Source text for Eikon:  ID: 
Further company coverage:  EMMW.SG 

 (Reporting by Clara Denina)
 ((Clara.Denina@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.